Original Article

Journal of Cerebral Blood Flow & Metabolism (2005) 25, 493–501. doi:10.1038/sj.jcbfm.9600058 Published online 2 February 2005

Obligatory role of inducible nitric oxide synthase in ischemic preconditioning

This work was supported by AHA grant 0030225N (SC) and NIH grants R37-NS34179 and RO1-NS35806 (CI). CI is the recipient of a Javits Award from NIH/NINDS.

Sunghee Cho1, Eun-Mi Park1, Ping Zhou1, Kelly Frys1, M Elizabeth Ross1 and Costantino Iadecola1

1Division of Neurobiology, Department of Neurology and Neuroscience, Weill Cornell Medical College, New York, New York, USA

Correspondence: Dr C Iadecola, Division of Neurobiology, 411 East 69th Street, room KB410, New York, NY 10021, USA. E-mail: coi2001@med.cornell.edu

Received 21 October 2004; Revised 8 November 2004; Accepted 9 November 2004; Published online 2 February 2005.

Top

Abstract

Sublethal insults can induce a transient tolerance toward subsequent lethal ischemia, a phenomenon termed ischemic preconditioning (IPC). In the myocardium, nitric oxide derived from 'inducible' nitric oxide synthase (iNOS or NOS II) plays a critical role in the expression of IPC produced by sublethal ischemia. Here, we investigated whether iNOS is involved in IPC in brain. Ischemic preconditioning was produced in mice by three episodes of 1-min bilateral common carotid artery (BCCA) occlusion, each followed by 5 mins of reperfusion. After 24 h, mice underwent middle cerebral artery (MCA) occlusion for 20 mins. Intraischemic cerebral blood flow was monitored during both in BCCA and MCA occlusion (MCAO) by laser-Doppler flowmetry. Mice were killed 3 days after MCAO, and infarct volume was determined in thionine-stained sections. Infarct volume was significantly reduced 24 h after IPC (70%; P<0.05). Treatment with the iNOS inhibitor aminoguanidine (400 mg/kg), abolished the IPC-induced protection. Furthermore, IPC failed to induce ischemic tolerance in iNOS-null mice. In wild-type mice, IPC increased the resistance to Ca2+-mediated depolarization in isolated brain mitochondria. However, in iNOS-null mice IPC failed to induce such resistance. We conclude that iNOS is required for the full expression of IPC and that such effect is coupled to an increased resistance of mitochondria to injury. Thus, iNOS-derived nitric oxide, in addition to its deleterious effects on the late stages of ischemic brain damage, can also be beneficial by promoting ischemic tolerance through signaling, ultimately resulting in mitochondrial protection.

Keywords:

aminoguanidine, iNOS-null mice, ischemic preconditioning, mitochondria

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

Extra navigation

.

naturejobs

natureproducts


ADVERTISEMENT